中文The 55th German International Hospital and Medical Equipment Exhibition (MEDICA) was successfully held in Dusseldorf, Germany from November 13th to 16th, 2023. MEDICA 2023 is recognized as one of the largest hospital and medical equipment exhibitions in the world, renowned for its unparalleled scale and influence. It attracts more than 5,000 companies from over 70 countries and regions to participate every year.
At this event, igenesis showcased its self-developed and produced Automated Fully Enclosed qPCR System -- Galaxy series and a variety of supporting reagents, which attracted many exhibitors. Experts, enterprise representatives, and visitors from all over the world, gathered around the exhibition hall. The crowd was surging, and the atmosphere was lively. Our expert team showcased the innovation and technical strength of igenesis in the field of POCT molecular diagnostics products, making them have a deeper understanding of our products. Our products won the favor and interest of many people with its advanced technology and innovation.
Automated Fully Enclosed qPCR System-Galaxy Series
Igenesis Automated Fully Enclosed qPCR System, coupled with iCassette (PCR-fluorescence method), can complete the whole process of nucleic acid extraction, purification, and fluorescent PCR amplification in three steps, all fully automated and enclosed. The system automatically generates experimental results, truly achieving “sample in, result out.”
Product Advantages
◆Intelligent: Automate the whole process of fluorescent PCR, Sample in-Result out, Lower operator requirements;
◆Integrated: Extraction+Amplification+Detection in one, no additional equipment required;
◆Fully Enclosed: Eliminate sample cross-contamination, no aerosol risk, and biosafety;
◆Multiplex qPCR Detection: 7 color fluorescent channels for multiplex detection;
◆Rapid Detection: 1~2 hours to get results, shorten turn-around time.
iCassette® - Open Platform
iCassette® has an intelligent patented structure and an unique open integration capability, which can quickly integrate third-party PCR detection reagents into iCassette® to form an integrated molecular POCT detection product application, which greatly saves the development cycle and cost of the product. With the Galaxy Automated Fully Enclosed qPCR System, the nucleic acid detection process can be fully enclosed. It can realize rapid pathogen nucleic acid extraction, purification and detection in diversified scenarios such as clinics, emergency rooms, clinical departments, bedside, and central laboratories.
Compatibility and flexibility
⚫ Adaptation of third-party PCR reagents
⚫ Customized collaboration mode
⚫ 7-colour fluorescent system, Up to 54 multiple targets
Igenesis’s internationalization strategy is a crucial driving force for the company's sustainable development. This year, igenesis has participated in exhibitions such as Denmark ECCMID, China CACLP, US ADLM, and Germany MEDICA. Its overseas business is distributed globally, such as Italy, Chile, Malaysia, Spain, Denmark, Hong Kong, China and Europe, South America, Southeast Asia and other regions. In the future, igenesis will adhere to the corporate philosophy of “integrity, excellence, innovation, and win-win”, and strive to become a leader in instant molecular diagnosis combining high technology and biotechnology. It will continue to explore the infinite possibilities of gene detection, and provide customers with safe, fast, convenient, accurate molecular diagnostic integrated products, services, and solutions.
Post time: Nov-22-2023